A curated list of the highest quality* peer reviewed medical research on Covid-19, sortable by citations, impact factor and tags

Inclusion criteria: the paper in question is relevant to SARS-Cov-2-virus (a.k.a HCov-19 and SARS-2); the disease caused by this virus, COVID-19; preventing the spread of this virus and treatment of the disease. This table is compiled from over 1600 peer-reviewed articles based on the impact factor of the journal, citations, altmetrics provided by Meltwater and human review.

*Methods disclaimer: Inclusion on this list does not constitute endorsement. We provide no claims or guarantees that our search was exhaustive or that our evaluation methodology is suitable for any kind of purpose. Subjective human evaluation has gone into determining cut-off values for impact factor based on the research type and the studied population: for example, describing the clinical picture of paediatric patients may be valuable, high-quality research despite being published in a journal with an impact factor of 5. Citations are of limited use for novel research topics, and must be kept up-to-date manually, as citation counts are behind paywalls and we know of no legal public API to retrieve this data.

Links to more research: After initially conducting the search manually, our primary source for new inclusions is now the recently launched LitCovid portal maintained by the United States National Library of Medicine (NLM) at the National Institutes of Health and the collection of Covid-19 related research maintained by WHO as our source for new papers to evaluate. For those interested in this topic we would also recommend having a look at the datasets and tools published by Microsoft Academic and Semantic Scholar.

This is not medical advice. This website is not a medical device, it is not suitable for self-diagnosis. Biohackers and quantified selfers: beware, here be dragons. We discourage anyone from drawing conclusions from any single studies.

Blatant volunteer recruiting plug: This page is an offshoot of Pandemia.fi - a newsroom and information resource in Finnish. We're fighting misinformation, disinformation, clickbait, news overload and inaction. We are looking for contributors, especially those who can bring data to life with interactive visualisations. We are tracking multiple domestic and global data sources to bring a sense of the COVID-19 crisis to our readers and have a large volunteer research team to provide ideas, compile data from research and help estimate clinical parameters for models. The new web app itself will be fully open-source and it is being built using React, Rebass, and Apex Charts (Github). Other tools are welcome as well! Currently we have a small group of core contributors. If the above sounds interesting consider jumping aboard and having an impact!

Credit: Pandemia.fi translational medicine team. Editors in chief: Daniel Jyllikoski , Otto Juote and Jari Kuikanmäki.

Contact: [email protected], +358 9 2316 3506.

DateArticleAuthorCitationsJournalIFTags
24.1.2020Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaHuang et al.1012The Lancet59clinical picturen=41
4.2.2020CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)Chung et al.90Radiology7.6clinical picturen=21
19.2.2020Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China Zhang et al.30Allergy6.8clinical picturen=140
28.2.2020Clinical Characteristics of Coronavirus Disease 2019 in ChinaGuan et al.102NEJM70.7clinical picturen=1099
24.2.2020Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China. Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and PreventionWu et McGoogan114JAMA51.3clinical pictureepidemiologySARS/MERSn=72314
5.3.2020First Case of 2019 Novel Coronavirus in the United StatesHolshue et al.256NEJM70.7clinical picturetransmissionn=1
15.2.2020Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive studyChen et al.537The Lancet59clinical picturen=99
5.3.2020Transmission of 2019-nCoV Infection from an Asymptomatic Contact in GermanyRothe et al.224NEJM70.7clinical picture
5.3.2020First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020.Spiteri et al.1Eurosurveill7.4epidemiologytransmissionn=38
13.3.2020Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.Wu et al.1JAMA51.3risk factors for severe disease; hoiton=201
13.3.2020Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality.Wilson et al.0Emerg Infect Dis7.4mortality
13.3.2020Estimating Risk for Death from 2019 Novel Coronavirus Disease, China, January–February 2020Mizumoto et Chowell0Emerg Infect Dis7.4mortality
11.3.2020Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyZhou et al.8The Lancet59clinical picturemortalityn=191
21.2.2020Presumed Asymptomatic Carrier Transmission of COVID-19Bai et al.63JAMA51.3transmissionn=5
12.3.2020A case report of neonatal COVID-19 infection in China.Wang et al.0Clin Infect Dis.9.1clinical picture
17.2.2020Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data.Lintone et al.13J Clin Med5.5incubation
17.5.2016Effectiveness of N95 respirators versus surgical masks in protecting health care workers from acute respiratory infection: a systematic review and meta-analysisSmith et al.31CMAJ6.9preventing spread
13.3.2020From Containment to Mitigation of COVID-19 in the USParodi et Liu0JAMA51.3preventing spread
9.3.2020How will country-based mitigation measures influence the course of the COVID-19 epidemic?Anderson et al.8Lancet59preventing spread
13.3.2020What Does the Coronavirus Disease 2019 (COVID-19) Mean for Families?Thompson et Rasmussen0JAMA Pediatrics12preventing spread
6.7.2011Physical interventions to interrupt or reduce the spread of respiratory virusesJefferson et al.294Cochrane Database of Systematic Reviews7.8transmissionpreventing spread
19.3.2020SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected PatientsZou et al.65NEJM70.7transmissionvirusn=18
24.2.2020Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populationsCao et al.4Cell Disc4.6virus
20.2.2020A Novel Coronavirus from Patients with Pneumonia in China, 2019Zhu et al.667NEJM70.7virusn=3
29.1.2020Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected PneumoniaLi et al.668NEJM70.7transmissionvirusincubationn=425
22.2.2020Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor bindingLu et al.319The Lancet59virus
27.2.2020The neuroinvasive potential of SARS‐CoV2 may be at least partially responsible for the respiratory failure of COVID‐19 patientsLi et al.2J Med Virol2.3virusneuro
6.3.2020SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorHoffmann et al.12Cell43.4virus
13.3.2020Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms.Baig et al. 0ACS Chem Neurosci4.3virusneuro
9.3.2020Preparing for COVID-19: early experience from an intensive care unit in SingaporeLiew et al.0BMC8.3
11.3.2020Virtually Perfect? Telemedicine for Covid-19.Hollander et Carr1NEJM70.7preventing spreadhealthcare
11.3.2020Coronavirus Disease 2019 (COVID-19): Protecting Hospitals From the Invisible.Klompas0Ann Intern Med.19.3preventing spread
11.3.2020How Should U.S. Hospitals Prepare for Coronavirus Disease 2019 (COVID-19)?Chopra et al.0Ann Intern Med.19.3treatmenthealthcare
11.3.2020Care for Critically Ill Patients With COVID-19Murthy et al.2JAMA51.3treatmenthealthcare
12.3.2020Audio Interview: Making Decisions about Covid-19 Testing and Treatment for Your PatientsRubin et al.0NEJM70.7preventing spreadhealthcare
12.3.2020Supporting the Health Care Workforce During the COVID-19 Global Epidemic.Adams et Walls1JAMA51.3healthcare
10.2.2020Therapeutic options for the 2019 novel coronavirus (2019-nCoV)Li et al.32Nat Rev Drug Disc57treatment
5.3.2020Of chloroquine and COVID-19.Touret et Lamballerie0Antiviral Res4.1treatment
4.3.2020Chloroquine and hydroxychloroquine as available weapons to fight COVID-19.Colson et al.2Int J Antimicrob Agents4.6treatment
20.2.2020Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China.Deng et Peng 7J Clin Med5.6treatment
4.2.2020Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitroWang et al.122Cell Res15.4treatment
13.3.2020Critical Care Utilization for the COVID-19 Outbreak in Lombardy, ItalyGrasselli et al.1JAMA51.3healthcare
12.3.2020Real estimates of mortality following COVID-19 infectionBaud et al.3Lancet Infect Dis27.5mortality
16.3.2020Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)Li et al.1Science41transmissionpreventing spread
17.3.2020The proximal origin of SARS-CoV-2Anderson et al.2Nature Med30.6virus
17.3.2020Perinatal Transmission of COVID-19 Associated SARS-CoV-2: Should We Worry?Fan et al.0Clin Infect Dis.9.1transmission
17.3.2020Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients.Salehi et al.0Am J Roentgenol3.2clinical picturen=919
12.3.2020Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical recordsChen et al.84The Lancet59clinical picturetransmissionn=10
13.3.2020Evolution of Computed Tomography Manifestations in Five Patients Who Recovered from Coronavirus Disease 2019 (COVID-19) Pneumonia.Sun et al.Kor J Radiol3.7clinical picture
17.3.2020COVID-19 and the Risk to Health Care Workers: A Case Report.Ng et al.Ann Intern Med19.3transmissionpreventing spread
18.3.2020Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19).Nishiura et al.2Int J Infect Dis3.5transmissionvirus
19.3.2020Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020.Mizumoto et al.1Eurosurveill7.4transmissionpreventing spread
19.3.2020Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis.Liu et al.Am J Roentgenol3.2clinical picturen=15
19.3.2020Facing Covid-19 in Italy - Ethics, Logistics, and Therapeutics on the Epidemic's Front Line.RosenbaumNEJM70.7
19.3.2020Audio Interview: New Research on Possible Treatments for Covid-19.Rubin et al.NEJM70.7treatmenthealthcare
18.3.2020A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19Cao et al.1NEJM70.7treatmentn=200
13.2.2020Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) PneumoniaPan et al.61Radiology7.6clinical picture
1.3.2020COVID-19 in Children: Initial Characterization of the Pediatric DiseaseCruz et al.Pediatrics5.4clinical picture
1.3.2020Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in ChinaDong et al.Pediatrics5.4clinical picturen=2143 (731 lab-confirmed)
17.3.2020Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1van Doremalen et al.NEJM70.7transmissionpreventing spread
3.3.2020Risk of COVID-19 for patients with cancerWang et Zhang1Lancet Oncol35.4
19.3.2020Viral dynamics in mild and severe cases of COVID-19Liu et al.Lancet Infect Dis27.5virus
17.3.2020COVID-19 in pregnant women – Authors' replyBaud et al.Lancet Infect Dis27.5transmissionpreventing spread
4.1.2017Universal and reusable virus deactivation system for respiratory protectionQuan et al.3Sci Repo4.5preventing spread
24.1.2020A novel coronavirus outbreak of global health concern.Wang et al.Lancet59
26.2.2020Diarrhoea may be underestimated: a missing link in 2019 novel coronavirusLiang et al.4Gut17.9clinical picture
24.2.2020Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to knowRasmussen et al.16Am J Obstet Gynecol6.1healthcare
20.3.2020Misguided drug advice for COVID-19FitzGeraldScience41treatment
21.3.2020SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?Kuster et al.Eur Heart J24.9treatment
21.3.2020Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?Esler et al.J Hypertens4.7treatment
16.3.2020Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019:a retrospective cohort study.Deng et al.J Infect4.6treatment
6.3.2020Managing neonates with respiratory failure due to SARS-CoV-2 – Authors' replyWang et ShiLancet Child Adolesc HealthN/A - new journal treatmenthealthcare
21.3.2020Rhabdomyolysis as Potential Late Complication Associated with COVID-19.Jin et al.Emerg Infect Dis7.4clinical picturen=1
21.3.2020Early Introduction of Severe Acute Respiratory Syndrome Coronavirus 2 into EuropeOlsen et al.Emerg Infect Dis7.4clinical picturetransmission
17.3.2020Perinatal Transmission of COVID-19 Associated SARS-CoV-2: Should We WorryFan et al.clin infect Dis.9.1transmission
25.3.2020COVID-19 Illness in Native and Immunosuppressed States: A Clinical-Therapeutic Staging ProposalSidiqqi et al.JOURNAL OF HEART AND LUNG TRANSPLANTATION7.1clinical picture
19.3.2020Viral dynamics in mild and severe cases of COVID-19Liu et al.Lancet Infect Dis27.5transmissionvirus
19.3.2020Prolonged presence of SARS-CoV-2 viral RNA in faecal samplesWu et al.The Lancet Gastroenterology and Hepatology12.9transmissionvirus
22.3.2020COVID-19 in gastroenterology: a clinical perspectiveOng et al.Gut17.9clinical picture
20.3.2020Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitorsZhang et al.Science41virustreatment
19.3.2020Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 OutbreakZhang et al.Current Biology9.2virus
20.3.2020Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside WuhanShi et al.Crit Care6.9clinical picturehealthcare
20.3.2020Serial Interval of COVID-19 among Publicly Reported Confirmed Cases.Du et al.Emerg Infect Dis7.4
31.3.2020Clinical Characteristics of 54 medical staff with COVID-19: A retrospective study in a single center in Wuhan, China.Chu et al.J Med Virol2.4clinical picture
31.3.2020Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19).Alhazzani et al.Intensive Care Med19treatmenthealthcare
31.3.2020Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infectionHenri et LippiNephrologyn=237
26.3.2020Antihypertensive drugs and risk of COVID-19?Lo et al.The Lancet Resp Med23treatment
26.3.2020Antihypertensive drugs and risk of COVID-19?Tignanelli et al.The Lancet Resp Med23treatment
29.3.2020Review article: Gastrointestinal features in COVID-19 and the possibility of faecal transmission.Tian et al.Aliment Pharmacol Ther7.4clinical picturetransmission
18.3.2020Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries.Kandel et al.The Lancet59healthcare
21.3.2020COVID-19: consider cytokine storm syndromes and immunosuppression.Puja et al.The Lancet59clinical picturetreatment
17.3.2020Clinical course and mortality risk of severe COVID-19.Weiss et MurdochThe Lancet59clinical picture
11.3.2020Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.Zhou et al.The Lancet59clinical picture
26.3.2020COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?Patel et VermaJAMA51.3treatment
26.3.2020Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her NewbornDong et al.JAMA51.3transmission
23.3.2020Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.Onder et al.JAMA51.3clinical picture
19.3.2020Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.Arentz et al.JAMA51.3clinical picture
25.3.2020Critical Supply Shortages — The Need for Ventilators and Personal Protective Equipment during the Covid-19 PandemicRanney et al.NEJM70.7transmissionhealthcare
23.3.2020Fair Allocation of Scarce Medical Resources in the Time of Covid-19Emanuel et al.NEJM70.7healthcare
1.4.2020Virological assessment of hospitalized patients with COVID-2019Wölfen et al.Nature43transmissionvirus